Hudson Bay Capital Management
IGMS

Hudson Bay Capital Management’s IGM Biosciences IGMS Stock Holding History

Hudson Bay Capital Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-46,119
Closed -$317K – 945
2024
Q2 		$317K Buy
+46,119
New +$395K ﹤0.01% 657
2024
Q1 		– Sell
-124,260
Closed -$1.03M – 800
2023
Q4 		$1.03M Hold
124,260
– – 0.01% 517
2023
Q3 		$1.04M Buy
+124,260
New +$1.05M 0.01% 559

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hudson Bay Capital Management's IGMS Position: Q3 2024 in Review

Hudson Bay Capital Management sold out of IGM Biosciences (IGMS) in Q3 2024, closing a stake of 46,119 shares — an estimated $317K sold.

Hudson Bay Capital Management first reported a position in IGMS in Q3 2023 and held it in 3 quarters. The position peaked at $1.04M in Q3 2023. 72 funds tracked by Wall St. Rank hold IGMS as of Q3 2024.

  • Hudson Bay Capital Management reported no remaining IGM Biosciences position as of Q3 2024 after selling out during the quarter.
  • Hudson Bay Capital Management sold 46,119 IGM Biosciences shares in Q3 2024, an estimated $317K.
  • Hudson Bay Capital Management first reported a position in IGM Biosciences in Q3 2023 and held it in 3 quarters.
  • Hudson Bay Capital Management's IGM Biosciences position peaked at $1.04M in Q3 2023.
  • 72 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2024.

Based on Hudson Bay Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.